Download Acute Pancreatitis Clinical Presentation

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Artificial pancreas wikipedia , lookup

Cofactor engineering wikipedia , lookup

Dental emergency wikipedia , lookup

List of medical mnemonics wikipedia , lookup

Transcript
Presented by:
Ahmad Pourhosseini
common bile
duct
BODY
TAIL
HEAD
pancreatic duct
ampulla
UNCINATE
pancreatic enzymes
PROTEOLYTIC
ENZYMES
Trypsinogen
Chymotrypsinogen
Proelastase
Procarboxypeptidase A
Procarboxypeptidase B
AMYOLYTIC ENZYMES
Amylase
LIPOLYTIC ENZYMES
Lipase
Prophospholipase A2
Carboxylesterase lipase
NUCLEASES
Deoxyribonuclease (DNAse)
Ribonuclease (RNAse)
OTHERS
Procolipase
Trypsin inhibitor
 COMPARTMENTALIZATION - digestive enzymes are contained
within zymogen granules in acinar cells
 REMOTE ACTIVATION - digestive enzymes are secreted as
inactive proenzymes within the pancreas
 PROTEASE INHIBITORS – trypsin inhibitor is secreted along
with the proenzymes to suppress any premature enzyme
activation
 AUTO “SHUT-OFF” – trypsin destroys trypsin in high
concentrations
 Acute inflammatory process involving the
pancreas
 Usually painful and self-limited
 Isolated event or a recurring illness
 Pancreatic function and morphology return to
normal after (or between) attacks
Idiopathic
10%
Other
10%
EtOH
35%
Gallstones
45%
 Cholelithiasis
 Pancreas divisum
 Ethanol abuse
 Hereditary
 Idiopathic
 Hypercalcemia
 Medications
 Viral infections
 Hyperlipidemia
 Mumps
 ERCP
 Coxsackievirus
 Trauma
 End-stage renal failure
 Penetrating peptic ulcer
 AIDS therapy: didanosine, pentamidine
 Anti-inflammatory: sulindac, salicylates
 Antimicrobials: metronidazole, sulfonamides, tetracycline,





nitrofurantoin
Diuretics: furosemide, thiazides
IBD: sulfasalazine, mesalamine
Immunosuppressives: azathioprine, 6-mercaptopurine
Neuropsychiatric: valproic acid
Other: calcium, estrogen, tamoxifen, ACE-I
 Autosomal dominant with 80% phenotypic
penetrance
 Recurrent acute pancreatitis, chronic pancreatitis, and
50-fold increased risk of pancreatic cancer
 Mutation in cationic trypsinogen gene (R122H)
 Other genetic defects
 CFTR
 SPINK1
acinar cell
injury
premature
enzyme activation
failed protective
mechanisms
premature enzyme activation
autodigestion of pancreatic tissue
local
vascular
insufficiency
local
complications
activation
of white
blood cells
release of
enzymes into
the circulation
distant
organ failure
SEVERITY
Mild
 STAGE 1: Pancreatic Injury
 Edema
 Inflammation
 STAGE 2: Local Effects
 Retroperitoneal edema
 Ileus
 STAGE 3: Systemic Complications
 Hypotension/shock
 Metabolic disturbances
 Sepsis/organ failure
Severe
Acute Pancreatitis
Clinical Presentation
 Abdominal pain
 Epigastric
 Radiates to the back
 Worse in supine position
 Nausea and vomiting
 Fever
 Choledocholithiasis
 Perforated ulcer
 Mesenteric ischemia
 Intestinal obstruction
 Ectopic pregnancy
Acute Pancreatitis
 Symptoms
Diagnosis
 Abdominal pain
 Laboratory
 Elevated amylase or lipase
 > 3x upper limits of normal
 Radiology
 Abnormal sonogram or CT
 Grey Turner sign - flank discoloration due to
retroperitoneal bleed in pt. with pancreatic necrosis
(rare)
 Cullen’s sign - periumbilical discoloration (rare)
Grey Turner sign
Cullen’s sign
Amylase
Lipase
↑
Intestinal injury
↑
↑
↑
↑
Tubo-ovarian
disease
↑
Normal
Renal failure
↑
↑
↑
Pancreatitis
Parotitis
Biliary stone
Macroamylasemia
Normal
↑
↑
Normal
 EtOH: history
 Gallstones: abnormal LFTs & sonographic evidence of




cholelithiasis
Hyperlipidemia: lipemic serum, Tri>1,000
Hypercalcemia: elevated Ca
Trauma: history
Medications: history, temporal association
Acute Pancreatitis
Clinical Manifestations
PANCREATIC
PERIPANCREATIC
Mild: edema, inflammation, fat necrosis
Severe: phlegmon, necrosis, hemorrhage,
infection, abscess, fluid collections
Retroperitoneum, perirenal spaces, mesocolon,
omentum, and mediastinum
Adjacent viscera: ileus, obstruction, perforation
SYSTEMIC
Cardiovascular: hypotension
Pulmonary: pleural effusions, ARDS
Renal: acute tubular necrosis
Hematologic: disseminated intravascular coag.
Metabolic: hypocalcemia, hyperglycemia
ER presentation
0
12
cytokine release
24
36
48
organ failure
60
hours from pain onset
72
84
96
 Why are they needed?
 appropriate patient triage & therapy
 compare results of studies of the impact of therapy
 When are they needed?
 optimally, within first 24 hours (damage control must
begin early)
 Which is best?
Ranson Criteria (1974)
 based on clinical & laboratory parameters
 scored in first 24-48 hours of admission
 poor positive predictors (better negative predictors)
 APACHE Scoring System
 can yield a score in first 24 hours
 APACHE II suffers from poor positive predictive value
 APACHE III is better at mortality prediction at > 24 hours
 Computed Tomography Severity Index
 much better diagnostic and predictive tool
 optimally useful at 48-96 hours after symptom onset

Number
Mortality
<2
3-4
1% 16%
5-6
40%
7-8
100%
appearance
normal
enlarged
inflamed
1 fluid
collection
2 or more
collections
grade
A
B
C
D
E
score
0
1
2
3
4
necrosis
none
< 33%
33-50%
> 50%
score
0
2
4
6
score
morbidity
mortality
1-2
4%
0%
7-10
92%
17%
Balthazar et al. Radiology 1990.
 Scoring systems
  3 Ranson criteria
  8 APACHE II points
  5 CT points
 Organ failure
 shock (SBP < 90 mmHg)
 pulmonary edema / ARDS (PaO2 < 60 mmHg)
 renal failure (Cr > 2.0 mg/dl)
 Local complications
 fluid collections  pseudocysts
 necrosis (mortality 15% if sterile, 30-35% if
infected)
 abscess
 Pancreatic rest
 Supportive care
 fluid resuscitation – watch BP and urine output
 pain control
 NG tubes and H2 blockers or PPIs are usually not
helpful
 Refeeding (usually 3 to 7 days)
 bowel sounds present
 patient is hungry
 nearly pain-free (off IV narcotics)
 amylase & lipase not very useful here
Pancreatic rest & supportive care
 fluid resuscitation* – may require 5-10 liters/day
 careful pulmonary & renal monitoring – ICU
 maintain hematocrit of 26-30%
 pain control – PCA pump
 correct electrolyte derangements (K+, Ca++, Mg++)
 Rule-out necrosis
 contrasted CT scan at 48-72 hours
 prophylactic antibiotics if present
 surgical debridement if infected
 Nutritional support
 may be NPO for weeks
 TPN vs. enteral support (TEN)

 Abdominal pain with food aversion
 Nausea and vomiting
 Gastric atony
 Ileus
 Partial duodenal obstruction
Mild
Severe
Pancreatitis
Pancreatitis
80%
20%
No
Yes
80%
0%
Morbidity
8%
38%
Mortality
3%
27%
Parameter
Admissions
Pancreatic
necrosis
Oral diet within 5
days
 Acute pancreatitis is a self-limited disease in which
most cases are mild.
 Gallstones and alcohol are the leading causes of acute
pancreatitis.
 In mild pancreatitis, nutritional support is usually not
required
 In severe pancreatitis, nutritional support will likely be
required with the enteral route preferred over TPN
because of both safety and cost.